Chris Verslype
1999–2025 年に発表
- 110
- 論文数
- 23,213
- 被引用数
- 66
- h 指数
- 103
- i10 指数
被引用数
引用元
国・地域
機関
分野
- Medicine76.9%
- Biochemistry, Genetics and Molecular Biology16.3%
- Immunology and Microbiology3%
- Engineering0.7%
- Nursing0.6%
- Pharmacology, Toxicology and Pharmaceutics0.5%
- その他2%
トピック
- Hepatocellular Carcinoma Treatment and Prognosis10.9%
- Cancer Immunotherapy and Biomarkers5%
- Cholangiocarcinoma and Gallbladder Cancer Studies4.9%
- Colorectal Cancer Treatments and Studies4.2%
- Liver Disease Diagnosis and Treatment3.5%
- Pancreatic and Hepatic Oncology Research3.5%
- その他68%
共著者
- Eric Van Cutsem27
- Frederik Nevens27
- Tania Roskams18
- Jeroen Dekervel17
- Wim Laleman15
- Jacques Pirenne13
- Vincent Vandecaveye13
- Arndt Vogel12
- Jos van Pelt12
- Christophe M. Deroose11
- Jens Ricke11
- Bruno Sangro10
- David Cassiman10
- Bruno Daniele9
- Geert Maleux9
- Raymond Aerts9
- Baki Topal8
- Richard S. Finn8
- Abby B. Siegel7
- Alexander Wilmer7
- Hannah van Malenstein7
- Josep M. Llovet7
- Julien Edeline7
- Karen Geboes7
全論文
- Pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib (KEYNOTE-224): a non-randomised, open-label phase 2 trial
著者: Andrew X. Zhu, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Lætitia Fartoux, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Andrea L. Webber, Scot Ebbinghaus, Junshui Ma, Abby B. Siegel, Ann‐Lii Cheng, Masatoshi Kudo, Angela Alistar, Jamil Asselah, Jean‐Frédéric Blanc, Ivan Borbath, Timothy Lewis Cannon, Ki Y. Chung, Allen Lee Cohn, David Cosgrove, Nevena Damjanov, Mukul Gupta, Yoshivasu Karino, Mark Karwal, Andreas Kaubisch, Robin Kate Kelley, Jena-Luc Van Laethem, Timothy Larson, James Lee, Daneng Li, Atisha Manhas, Gulam A. Manji, Kazushi Numata, Benjamin M. Parsons, Andrew Scott Paulson, Carmine Pinto, Robert A. Ramirez, Suresh Ratnam, Magnus Rizell, Olivier Rosmorduc, Yvonne H. Sada, Yutaka Sasaki, Per Stål, Simone I. Strasser, Joerg Trojan, Gina M. Vaccaro, Hans Van Vlierberghe, Alan Weiss, Karl-Heinz Weiss, Tatsuya Yamashita - The Lancet Oncology 2018 被引用: 2,536
- Pembrolizumab in combination with gemcitabine and cisplatin compared with gemcitabine and cisplatin alone for patients with advanced biliary tract cancer (KEYNOTE-966): a randomised, double-blind, placebo-controlled, phase 3 trial
著者: Robin Kate Kelley, Makoto Ueno, Changhoon Yoo, Richard S. Finn, Junji Furuse, Zhenggang Ren, Thomas Yau, Heinz‐Josef Klümpen, Stephen L. Chan, Masato Ozaka, Chris Verslype, Mohamed Bouattour, Joon Oh Park, Olga Barajas, Uwe Pelzer, Juan W. Valle, Li Yu, Usha Malhotra, Abby B. Siegel, Julien Edeline, Arndt Vogel, Mehmet Akce, Inmaculada Alés Díaz, Gustavo R. Alves, Sumitra Anand, Çağatay Arslan, Jamil Asselah, Eric Assénat, Eric Assenat, Li‐Yuan Bai, Yuxian Bai, Olga Barajas, Susan E. Bates, Stephen Begbie, Irit Ben‐Aharon, Nina Beri, Marie‐Luise Berres, Jean‐Frédéric Blanc, Ivan Borbath, Robert Bordonaro, Mohamed Bouattour, Giovanni Brandi, Adam M. Burgoyne, Kritiya Butthongkomvong, Marcos Pedro Guedes Camandaroba, Ke Cao, Marcela Carballido, Marcela Carballido, Jen‐Shi Chen, Ming‐Huang Chen, Ming-Huang Chen, Ashley Cheng, Tai‐Jan Chiu, Hye Jin Choi, Hong Jae Chon, Joëlle Collignon, Antonio Cubillo Gracián, S. Lindsey Davis, Ricardo Saraiva de Carvalho, D.J.A. de Groot, Anne Demols, Judith de Vos, Maria Diab, Jacob C. Easaw, Martin Eatock, Julien Edeline, Rawad Elias, Fredericus Eskens, Alfredo Falcone, Plinio Fernández, Richard S. Finn, Fábio Franke, Masayuki Furukawa, Junji Furuse, Olumide B. Gbolahan, Karen Geboes, Keri-Lee Geneser, Zhimin Geng, Ravit Geva, Roopinder Gillmore, Thorsten Oliver Goetze, Hongfeng Gou, Julieta Grasselli, Shanzhi Gu, Mahmut Gümüş, Nadia Haj Mohammad, Chunyi Hao, Hakan Harputluoğlu, Hassan Hatoum, Volker Heinemann, Wang Kwong Ho, Chiun Hsu, Ayala Hubert, Jun‐Eul Hwang, Mevlüde İnanç, Soledad Iseas, Vaishnavi Jeyasingam, Paula Jiménez Fonseca, Warren Joubert, Jitlada Juengsamarn ほか 116 名 - The Lancet 2023 被引用: 1,025
- Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up
著者: Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, J -C Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli - Annals of Oncology 2018 被引用: 1,070
- Evidence for an alternative fatty acid desaturation pathway increasing cancer plasticity
著者: Kim Vriens, Stefan Christen, Sweta Parik, Dorien Broekaert, Kazuaki Yoshinaga, Ali Talebi, Jonas Dehairs, Carmen Escalona‐Noguero, Roberta Schmieder, Thomas Cornfield, Catriona Charlton, Laura Romero‐Pérez, Matteo Rossi, Gianmarco Rinaldi, Martin F. Orth, Ruben Boon, Axelle Kerstens, Suet‐Ying Kwan, Brandon Faubert, Andrés Méndez‐Lucas, Charlotte Kopitz, Ting Chen, Juan Fernández-García, João Duarte, Arndt A. Schmitz, Patrick Steigemann, Mustapha Najimi, Andrea Hägebarth, Jo A. Van Ginderachter, Étienne Sokal, Naohiro Gotoh, Kwok‐Kin Wong, Catherine M. Verfaillie, Rita Derua, Sebastian Munck, Mariia Yuneva, Laura Beretta, Ralph J. DeBerardinis, Johannes V. Swinnen, Leanne Hodson, David Cassiman, Chris Verslype, Sven Christian, Sylvia Grünewald, Thomas G. P. Grünewald, Sarah‐Maria Fendt - Nature 2019 被引用: 484
- Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
著者: David Cunningham, Yves Humblet, Salvatore Siena, David Khayat, Harry Bleiberg, Armando Santoro, D. Bets, M. Mueser, A. Harstrick, Chris Verslype, Ian Chau, Eric Van Cutsem - New England Journal of Medicine 2004 被引用: 5,049
- Updated treatment recommendations for hepatocellular carcinoma (HCC) from the ESMO Clinical Practice Guidelines
著者: Arndt Vogel, Erika Martinelli, Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, Ulf P. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli - Annals of Oncology 2021 被引用: 458
- The management of hepatocellular carcinoma. Current expert opinion and recommendations derived from the 24th ESMO/World Congress on Gastrointestinal Cancer, Barcelona, 2022
著者: Michel Ducreux, Ghassan K. Abou‐Alfa, Tanios Bekaii‐Saab, Jordan Berlin, Andrés Cervantes, Thierry de Baère, Charis Eng, Peter R. Galle, Sharlene Gill, Thomas Gruenberger, Karin Haustermans, Ángela Lamarca, Pierre Laurent‐Puig, Josep M. Llovet, F. Lordick, Teresa Macarulla, Deborah Mukherji, Kei Muro, Radka Obermannová, Juan Manuel O’Connor, Eileen M. O’Reilly, Pia Österlund, P. A. Philip, G. Prager, Erika Ruíz‐García, Bruno Sangro, Thomas Seufferlein, Josep Tabernero, Chris Verslype, Harpreet Wasan, Eric Van Cutsem - ESMO Open 2023 被引用: 161
- Molecular predictors of prevention of recurrence in HCC with sorafenib as adjuvant treatment and prognostic factors in the phase 3 STORM trial
著者: Roser Pinyol, Robert Montal, Laia Bassaganyas, Daniela Sia, Tadatoshi Takayama, Gar-Yang Chau, Vincenzo Mazzaferro, Sasan Roayaie, Han Chu Lee, Norihiro Kokudo, Zhongyang Zhang, Sara Torrecilla, Agrin Moeini, Leonardo Rodríguez‐Carunchio, Edward Gane, Chris Verslype, Adina Croitoru, Umberto Cillo, Manuel de la Mata, L. Lupo, Simone I. Strasser, Joong‐Won Park, Jordi Camps, Manel Solé, Swan N. Thung, Augusto Villanueva, Carol Peña, Gerold Meinhardt, Jordi Bruix, Josep M. Llovet - Gut 2018 被引用: 335
- Molecular Markers of Response to Anti-PD1 Therapy in Advanced Hepatocellular Carcinoma
著者: Philipp K. Haber, Florian Castet, Miguel Torres‐Martín, Carmen Andreu-Oller, Marc Puigvehí, Maeda Miho, Pompilia Radu, Jean‐François Dufour, Chris Verslype, Carolin Zimpel, Jens U. Marquardt, Peter R. Galle, Arndt Vogel, Melanie Bathon, Tim Meyer, Ismaïl Labgaa, Antonia Digklia, Lewis R. Roberts, Mohamed A. Mohamed Ali, Beatriz Mínguez, Davide Citterio, Vincenzo Mazzaferro, Fabian Finkelmeier, Jörg Trojan, Burcin Özdirik, Tobias Müller, Moritz Schmelzle, Anthony Bejjani, Max W. Sung, Myron Schwartz, Richard S. Finn, Swan N. Thung, Augusto Villanueva, Daniela Sia, Josep M. Llovet - Gastroenterology 2022 被引用: 146
- Impact of combined selective internal radiation therapy and sorafenib on survival in advanced hepatocellular carcinoma
著者: Jens Ricke, Heinz‐Josef Klümpen, Holger Amthauer, Irene Bargellini, Peter Bartenstein, Enrico N. De Toni, Antonio Gasbarrini, Maciej Pech, Markus Peck‐Radosavljevic, Peter Popovič, Olivier Rosmorduc, Eckart Schott, Max Seidensticker, Chris Verslype, Bruno Sangro, Peter Malfertheiner - Journal of Hepatology 2019 被引用: 396
- Updated efficacy and safety of KEYNOTE-224: a phase II study of pembrolizumab in patients with advanced hepatocellular carcinoma previously treated with sorafenib
著者: Masatoshi Kudo, Richard S. Finn, Julien Edeline, Stéphane Cattan, Sadahisa Ogasawara, Daniel H. Palmer, Chris Verslype, Vittorina Zagonel, Lætitia Fartoux, Arndt Vogel, Debashis Sarker, Gontran Verset, Stephen L. Chan, Jennifer J. Knox, Bruno Daniele, Thomas Yau, Ellen B. Gurary, Abby B. Siegel, Anran Wang, Ann‐Lii Cheng, Andrew X. Zhu - European Journal of Cancer 2022 被引用: 129
- PD-1- CD45RA+ effector-memory CD8 T cells and CXCL10+ macrophages are associated with response to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma
著者: Sarah Cappuyns, Gino Philips, Vincent Vandecaveye, Bram Boeckx, Rogier Schepers, Thomas Van Brussel, Ingrid Arijs, Aurelie Mechels, Ayse Bassez, Francesca Lodi, Joris Jaekers, Halit Topal, Baki Topal, Orian Bricard, Junbin Qian, Eric Van Cutsem, Chris Verslype, Diether Lambrechts, Jeroen Dekervel - Nature Communications 2023 被引用: 82
- Pembrolizumab Monotherapy for Previously Untreated Advanced Hepatocellular Carcinoma: Data from the Open-Label, Phase II KEYNOTE-224 Trial
著者: Gontran Verset, Ivan Borbath, Mark Karwal, Chris Verslype, Hans Van Vlierberghe, Adel Kardosh, Vittorina Zagonel, Per Stal, Debashis Sarker, Daniel H. Palmer, Arndt Vogel, Julien Edeline, Stephane Cattan, Masatoshi Kudo, Ann-Lii Cheng, Sadahisa Ogasawara, Bruno Daniele, Stephen L. Chan, Jennifer J. Knox, Shukui Qin, Abby B. Siegel, Michael Chisamore, Ken Hatogai, Anran Wang, Richard S. Finn, Andrew X. Zhu - Clinical Cancer Research 2022 被引用: 84
- Keratin 19: a key role player in the invasion of human hepatocellular carcinomas
著者: Olivier Govaere, Mina Komuta, J. Berkers, Bart Spee, Carl Janssen, Francesca Luca, Aezam Katoonizadeh, Jasper Wouters, Léon C.L.T. van Kempen, Anne Durnez, Chris Verslype, Joery De Kock, Vera Rogiers, Leo A. van Grunsven, Baki Topal, Jacques Pirenne, Hugo Vankelecom, Frederik Nevens, Joost van den Oord, Massimo Pinzani, Tania Roskams - Gut 2013 被引用: 271
- Liver transplantation plus chemotherapy versus chemotherapy alone in patients with permanently unresectable colorectal liver metastases (TransMet): results from a multicentre, open-label, prospective, randomised controlled trial
著者: René Adam, Céline Piedvache, L. Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean‐Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valério Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Françis Lévi, M. Lewin, Maximiliano Gelli, Maximiliano Gelli, René Adam, René Adam, Céline Piedvache, Laurence Chiche, Jean Philippe Adam, Ephrem Salamé, Petru Bucur, Daniel Cherqui, Olivier Scatton, Victoire Granger, Michel Ducreux, Umberto Cillo, François Cauchy, Jean-Yves Mabrut, François Cauchy, Jean-Yves Mabrut, Chris Verslype, Laurent Coubeau, Jean Hardwigsen, Emmanuel Boleslawski, Fabrice Muscari, Heithem Jeddou, Denis Pezet, Bruno Heyd, Valerio Lucidi, Karen Geboes, Jan Lerut, Pietro Majno, Lamiae Grimaldi, Francis Levi, Maïté Lewin, Maximiliano Gelli, Olivier Soubrane, Mickael Lesurtel, Jean Baptsite Bachet, Samuel Lesourd, Marine Jary, Mohamed Bouattour, Sara Lonardi, Mohamed Hebbar, Karim Boudjema, Denis Smith, Mircea Chirica, Thierry Lecomte, Chirstophe Borg, Rosine Guimbaud, Julien Taieb, Patrizia Burra, Philippe Rougier, Joan Figueras - The Lancet 2024 被引用: 159
- Correction to: “Hepatocellular carcinoma: ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up”
著者: Arndt Vogel, Andrés Cervantes, Ian Chau, Bruno Daniele, Josep M. Llovet, Tim Meyer, Jean‐Charles Nault, U. Neumann, Jens Ricke, Bruno Sangro, Peter Schirmacher, Chris Verslype, Francis Zech, Dirk Arnold, Erika Martinelli - Annals of Oncology 2019 被引用: 276
- Phase III Trial of Bevacizumab in Combination With Gemcitabine and Erlotinib in Patients With Metastatic Pancreatic Cancer
著者: Eric Van Cutsem, Walter L. Vervenne, Jaafar Bennouna, Yves Humblet, Sharlene Gill, Jean‐Luc Van Laethem, Chris Verslype, Werner Scheithauer, Aijing Shang, Jan Cosaert, Malcolm J. Moore - Journal of Clinical Oncology 2009 被引用: 643
- 18F-AlF-NOTA-Octreotide Outperforms68Ga-DOTATATE/NOC PET in Neuroendocrine Tumor Patients: Results from a Prospective, Multicenter Study
著者: Elin Pauwels, Frederik Cleeren, Térence Tshibangu, Michel Koole, Kim Serdons, Lennert Boeckxstaens, Jeroen Dekervel, Timon Vandamme, Willem Lybaert, Bliede Van den Broeck, Annouschka Laenen, Paul M. Clément, Karen Geboes, Eric Van Cutsem, Sigrid Stroobants, Chris Verslype, Guy Bormans, Christophe M. Deroose - Journal of Nuclear Medicine 2022 被引用: 70
- Transition from laparoscopic to robotic liver surgery: clinical outcomes, learning curve effect, and cost-effectiveness
著者: Mathieu D’Hondt, A. Devooght, E. Willems, Dennis A. Wicherts, Céline De Meyere, Isabelle Parmentier, An‐Lies Provoost, Hans Pottel, Chris Verslype - Journal of Robotic Surgery 2022 被引用: 37
- Histological diversity in cholangiocellular carcinoma reflects the different cholangiocyte phenotypes
著者: Mina Komuta, Olivier Govaere, Vincent Vandecaveye, Jun Akiba, Werner Van Steenbergen, Chris Verslype, Wim Laleman, Jacques Pirenne, Raymond Aerts, Hirohisa Yano, Frederik Nevens, Baki Topal, Tania Roskams - Hepatology 2012 被引用: 330
- Hemicolectomy versus appendectomy for patients with appendiceal neuroendocrine tumours 1–2 cm in size: a retrospective, Europe-wide, pooled cohort study
著者: Cédric Nesti, Konstantin Bräutigam, Marta Benavent, Laura Bernal, Hessa Boharoon, Johan Botling, B Antonin, Iva Brčić, Maximilian Brunner, Guillaume Cadiot, María Cámara, Emanuel Christ, Thomas Clerici, Ashley Kieran Clift, H.W. Clouston, Lorenzo Cobianchi, Jarosław B. Ćwikła, Kosmas Daskalakis, Andrea Frilling, Rocio García‐Carbonero, Simona Grozinsky‐Glasberg, Jorge Hernando, Valérie Hervieu, Johannes Hofland, Pernille Holmager, Frediano Inzani, Henning Jann, Paula Jiménez‐Fonseca, Enes Kaçmaz, Daniel Kaemmerer, Gregory Kaltsas, Branislav Klimàcek, Ulrich Knigge, Agnieszka Kolasińska-Ćwikła, Walter Kolb, Beata Kos‐Kudła, Catarina Alisa Kunze, Stefania Landolfi, Stefano La Rosa, Carlos López, Kerstin Lorenz, Maurice Matter, Peter Mazal, Claudia Mestre‐Alagarda, Patricia Morales del Burgo, Els J.�M. Nieveen van Dijkum, Kira Oleinikov, Lorenzo A. Orci, Francesco Panzuto, Marianne Pavel, Marine Perrier, Henrik M. Reims, Guido Rindi, Anja Rinke, Maria Rinzivillo, Xavier Sagaert, I. Satiroglu, Andreas Selberherr, Alexander Siebenhüner, Margot Tesselaar, M. Thalhammer, Espen Thiis‐Evensen, Christos Toumpanakis, Timon Vandamme, José G. van den Berg, Alessandro Vanoli, Marie‐Louise F. van Velthuysen, Chris Verslype, Stephan A. Vorburger, Alessandro Lugli, John Ramage, Marcel Zwahlen, Aurel Perren, Reto M. Kaderli - The Lancet Oncology 2023 被引用: 66
- Three-year follow-up data from KEYNOTE-966: Pembrolizumab (pembro) plus gemcitabine and cisplatin (gem/cis) compared with gem/cis alone for patients (pts) with advanced biliary tract cancer (BTC).
著者: Richard S. Finn, Makoto Ueno, Changhoon Yoo, Zhenggang Ren, Junji Furuse, Robin Kate Kelley, Stephen L. Chan, Julien Edeline, Heinz‐Josef Klümpen, Thomas Yau, Chris Verslype, Masato Ozaka, Mohamed Bouattour, Joon Oh Park, Arndt Vogel, Juan W. Valle, Liis Starkopf, Usha Malhotra, Abby B. Siegel, Shukui Qin - Journal of Clinical Oncology 2024 被引用: 34
- 18F-Labeled Somatostatin Analogs as PET Tracers for the Somatostatin Receptor: Ready for Clinical Use
著者: Hannes Leupe, Stephen Ahenkorah, Jeroen Dekervel, Marcus Unterrainer, Eric Van Cutsem, Chris Verslype, Frederik Cleeren, Christophe M. Deroose - Journal of Nuclear Medicine 2023 被引用: 33
- Phase III Trial of Gemcitabine Plus Tipifarnib Compared With Gemcitabine Plus Placebo in Advanced Pancreatic Cancer
著者: Eric Van Cutsem, Helgi van de Velde, Petr Karásek, Helmut Oettle, Walter L. Vervenne, Andrzej Szawłowski, Patrick Schöffski, Stephanie Post, Chris Verslype, H Neumann, Howard Safran, Yves Humblet, Juan José Pérez Ruixo, Yue Ma, D. Von Hoff - Journal of Clinical Oncology 2004 被引用: 774
